<DOC>
	<DOCNO>NCT01580007</DOCNO>
	<brief_summary>Vitamin D exert effect via Vitamin D Receptor ( VDR ) present activate macrophage induces expression release cathelicidin , LL-37 , human antimicrobial peptide involve kill MTB . We aim investigate whether treatment newly diagnose pulmonary TB patient 2 month adjunctive PBA vitamin D ( Cholecalciferol ) combination standard DOTS therapy ( ) improve response standard short course TB therapy towards rapid recovery ; ( ii ) induce expression LL-37 macrophage ; ( iii ) enhance kill capacity macrophage isolate TB patient infect vitro MTB ; ( iv ) evoke adverse effect .</brief_summary>
	<brief_title>Clinical Trial Phenylbutyrate Vitamin D Tuberculosis ( TB )</brief_title>
	<detailed_description>This double-blind , randomize , placebo control clinical trial clinical efficacy phenylbutyrate vitamin D3 therapy daily 2 month newly diagnose sputum smear positive pulmonary TB patient . The clinical trial take place National Institute Diseases Chest Hospital ( NIDCH ) Dhaka , Bangladesh . Our specific aim : Objective 1 : To determine optimal oral dose PBA require induction antimicrobial peptide macrophages healthy adult . Objective 2 The second aim study determine whether adjunctive sodium phenylbutyrate vitamin D treatment ( 2 month ) newly diagnose pulmonary TB patient : 1 . Can improve response standard short course TB therapy towards rapid recovery ( clinical , radiological , mycobacterial ) . 2 . Can induce expression LL-37 macrophage ( immunological ) . 3 . Can enhance kill capacity macrophage TB patient infected vitro MTB ( functional measure treatment outcome ) . Study Design : The study randomize , double blind ( Subject , Caregiver , Investigator , Outcomes Assessor ) , placebo control trial 2 month . It also safety efficacy phase III study . The study 4x4 factorial design 4-cell intervention . Enrolled patient randomize follow four treatment arm 1:1:1:1 ratio : Group 1 : PBA Group 2 : Vitamin D3 ( Cholecalciferol ) Group 3 : PBA plus vitamin D3 Group 4 : Placebo</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<criteria>Adults , 1860 year sputum smear positive pulmonary TB New case Gender , Consent enroll study Hypercalcaemia ( serum calcium &gt; 2.6 mmol/L ) identify baseline Taking vitamin D Pregnant lactate Any know liver kidney function abnormality , malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>phenylbutyrate</keyword>
	<keyword>vitamin D</keyword>
	<keyword>cathelicidin</keyword>
	<keyword>antimicrobial peptide</keyword>
	<keyword>adult</keyword>
</DOC>